Tavalisse (fostamatinib)

pCPA File Number: 21827
Negotiation Status:
Negotiations were not pursued
Indication(s):
Chronic Immune Thrombocytopenia
Sponsor/Manufacturer:
Medison Pharma Canada Inc.
CDA-AMC Project Number:
SR0701-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: